Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
5,625,789
-
Shares change
-
-3,852,805
-
Total reported value, excl. options
-
$6,582,747
-
Value change
-
-$4,803,260
-
Put/Call ratio
-
4.5%
-
Number of buys
-
38
-
Number of sells
-
39
-
Price
-
$1.17
Institutional Holders of Protalix BioTherapeutics, Inc. - COM (PLX) as of Q2 2024
As of 30 Jun 2024 Protalix BioTherapeutics, Inc. - COM (PLX) had 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 5,625,789 shares of stock of the company.
Largest 10 holders included MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC, NORTHERN TRUST CORP, GSA CAPITAL PARTNERS LLP, BlackRock Inc., JANE STREET GROUP, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Y-Intercept (Hong Kong) Ltd, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This table shows 93 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.